| Total Revenue | | 0 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 1 | 0 | 0 |
| Gross Profit | | -1 | 0 | 0 |
| Selling, General and Administrative Excl. Other | | 71 | 49 | 25 |
| Research and Development | | 215 | 168 | 68 |
| Other Operating Expense | | -2 | 0 | 0 |
| Operating Income | | -286 | -217 | -93 |
| Interest Expense | | 0 | 0 | 0 |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | -30 | -35 | -9 |
| Net Income Before Taxes | | -256 | -182 | -84 |
| Income Taxes | | 0 | 0 | 0 |
| Consolidated Net Income | | -256 | -182 | -84 |
| Net Income From Continuing Operations | | -256 | -182 | -84 |
| Net Income | | -256 | -182 | -84 |
| EPS (Recurring) | | -4.22 | -3.30 | -1.66 |
| EPS (Basic, Before Extraordinaries) | | -4.22 | -3.30 | -1.66 |
| EPS (Diluted) | | -4.22 | -3.30 | -1.66 |
| EBITDA | | -254 | -182 | -75 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | — | — | — |
| Gross Margin | | — | — | — |
| Operating Margin | | — | — | — |
| Net Margin | | — | — | — |
| Shares Outstanding | | 61 | 55 | 51 |
| Market Capitalization | | 4,604 | — | — |
| Operating Lease Expense | | — | — | — |
